Advances in epidemiology, etiology, and treatment of community-acquired pneumonia.
10.3760/cma.j.cn112150-20220308-00214
- Author:
Ning JIANG
1
;
Qiu Yue LONG
2
;
Ya Li ZHENG
2
;
Zhan Chen GAO
1
Author Information
1. Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.
2. Department of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China.
- Publication Type:Journal Article
- MeSH:
Humans;
COVID-19;
Pneumonia/diagnosis*;
Community-Acquired Infections/drug therapy*;
Causality;
Risk Factors
- From:
Chinese Journal of Preventive Medicine
2023;57(1):91-99
- CountryChina
- Language:Chinese
-
Abstract:
Community-acquired pneumonia (CAP) is the third leading cause of death worldwide and one of the most commonly infectious diseases. Its epidemiological characteristics vary with host and immune status, and corresponding pathogen spectrums migrate over time and space distribution. Meanwhile, with the outbreak of COVID-19, some unconventional treatment strategies are on the rise. This article reviewed the epidemiological characteristics, pathogen spectrum and treatment direction of CAP in China over the years, and aimed to provide guidance for the diagnosis and treatment of CAP in clinical practice.
